Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Str8Shuteron Mar 25, 2021 2:44pm
123 Views
Post# 32876864

RE:RE:RE:Done loading up.

RE:RE:RE:Done loading up. I think that the market has evidently set rather low expectations that are already "baked into" the SP.  That is probably to be expected, having been in a prolonged technical "Stage 1", to borrow an observation from MarketMoney.    :-)

If the company launches on time and with a strong Q4 report, there will be a strong positive reaction in the SP.  Otherwise, if any delay or mediocre revenues, there could be some running for the exits.  Any negative reaction should be relatively muted though, versus what could happen if the market had set much higher expectations at this point.

So, overall, longs are probably in a fairly good position considering SZLS's risk-to-reward profile today.  GLTA!

frewil11 wrote: I feel that the longs here including myself that have waited for years for the launch of Aristotle are going to be dissapointed when it happens and there will be no reaction from the market or very little , others here feel the same way ?

<< Previous
Bullboard Posts
Next >>